These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 32740441)

  • 1. Low hospitalization rate without severe arrhythmias: a prospective survey on 350 patients early home treated with hydroxychloroquine during COVID-19 pandemic.
    Capucci A; Santarelli A; Bartolomei M; Paolizzi C; Biagetti C; Dappozzo A; Piovaccari G
    J Cardiovasc Med (Hagerstown); 2020 Nov; 21(11):922-923. PubMed ID: 32740441
    [No Abstract]   [Full Text] [Related]  

  • 2. Incidence of arrhythmias and electrocardiographic abnormalities in symptomatic pediatric patients with PCR-positive SARS-CoV-2 infection, including drug-induced changes in the corrected QT interval.
    Samuel S; Friedman RA; Sharma C; Ganigara M; Mitchell E; Schleien C; Blaufox AD
    Heart Rhythm; 2020 Nov; 17(11):1960-1966. PubMed ID: 32621881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin.
    Chorin E; Dai M; Shulman E; Wadhwani L; Bar-Cohen R; Barbhaiya C; Aizer A; Holmes D; Bernstein S; Spinelli M; Park DS; Chinitz LA; Jankelson L
    Nat Med; 2020 Jun; 26(6):808-809. PubMed ID: 32488217
    [No Abstract]   [Full Text] [Related]  

  • 4. COVID-19 and QT interval prolongation: more than just drug toxicity?
    Merino JL; Martínez-Cossiani M; Iniesta A; Escobar C; Rey JR; Castrejón-Castrejón S
    Europace; 2020 Oct; 22(10):1479. PubMed ID: 32441761
    [No Abstract]   [Full Text] [Related]  

  • 5. Considerations for Drug Interactions on QTc in Exploratory COVID-19 Treatment.
    Roden DM; Harrington RA; Poppas A; Russo AM
    Circulation; 2020 Jun; 141(24):e906-e907. PubMed ID: 32267732
    [No Abstract]   [Full Text] [Related]  

  • 6. Predictive factors for cardiac conduction abnormalities with hydroxychloroquine-containing combinations for COVID-19.
    Padilla S; Telenti G; Guillén L; García JA; García-Abellán J; Ding C; Mora A; García-Pachón E; Gutiérrez F; Masiá M;
    Int J Antimicrob Agents; 2020 Oct; 56(4):106142. PubMed ID: 32853675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QT Interval Prolongation Under Hydroxychloroquine/Azithromycin Association for Inpatients With SARS-CoV-2 Lower Respiratory Tract Infection.
    Bun SS; Taghji P; Courjon J; Squara F; Scarlatti D; Theodore G; Baudouy D; Sartre B; Labbaoui M; Dellamonica J; Doyen D; Marquette CH; Levraut J; Esnault V; Bun SS; Ferrari E
    Clin Pharmacol Ther; 2020 Nov; 108(5):1090-1097. PubMed ID: 32588427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial.
    Sivapalan P; Ulrik CS; Bojesen RD; Lapperre TS; Eklöf JV; Håkansson KEJ; Browatzki A; Tidemansen C; Wilcke JT; Janner J; Gottlieb V; Meteran H; Porsbjerg C; Madsen BL; Moberg M; Pedersen L; Benfield TL; Lundgren JD; Knop FK; Biering-Sørensen T; Ghanizada M; Sonne TP; Bødtger UCS; Jensen SG; Rasmussen DB; Brøndum E; Tupper OD; Sørensen SW; Alstrup G; Laursen CB; Møller UW; Sverrild A; Jensen JS
    Trials; 2020 Jun; 21(1):513. PubMed ID: 32522282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Considerations for drug interactions on QTc interval in exploratory COVID-19 treatment.
    Roden DM; Harrington RA; Poppas A; Russo AM
    Heart Rhythm; 2020 Jul; 17(7):e231-e232. PubMed ID: 32302703
    [No Abstract]   [Full Text] [Related]  

  • 10. Inpatient Use of Ambulatory Telemetry Monitors for COVID-19 Patients Treated With Hydroxychloroquine and/or Azithromycin.
    Chang D; Saleh M; Gabriels J; Ismail H; Goldner B; Willner J; Beldner S; Mitra R; John R; Epstein LM
    J Am Coll Cardiol; 2020 Jun; 75(23):2992-2993. PubMed ID: 32330546
    [No Abstract]   [Full Text] [Related]  

  • 11. Arrhythmic profile and 24-hour QT interval variability in COVID-19 patients treated with hydroxychloroquine and azithromycin.
    Cipriani A; Zorzi A; Ceccato D; Capone F; Parolin M; Donato F; Fioretto P; Pesavento R; Previato L; Maffei P; Saller A; Avogaro A; Sarais C; Gregori D; Iliceto S; Vettor R
    Int J Cardiol; 2020 Oct; 316():280-284. PubMed ID: 32439366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection.
    Juurlink DN
    CMAJ; 2020 Apr; 192(17):E450-E453. PubMed ID: 32269021
    [No Abstract]   [Full Text] [Related]  

  • 13. Reply to Gautret et al: hydroxychloroquine sulfate and azithromycin for COVID-19: what is the evidence and what are the risks?
    Machiels JD; Bleeker-Rovers CP; Ter Heine R; Rahamat-Langendoen J; de Mast Q; Ten Oever J; Bousema T; van Crevel R; Wertheim HF
    Int J Antimicrob Agents; 2020 Jul; 56(1):106056. PubMed ID: 32674929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State.
    Rosenberg ES; Dufort EM; Udo T; Wilberschied LA; Kumar J; Tesoriero J; Weinberg P; Kirkwood J; Muse A; DeHovitz J; Blog DS; Hutton B; Holtgrave DR; Zucker HA
    JAMA; 2020 Jun; 323(24):2493-2502. PubMed ID: 32392282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxychloroquine versus Azithromycin for Hospitalized Patients with Suspected or Confirmed COVID-19 (HAHPS). Protocol for a Pragmatic, Open-Label, Active Comparator Trial.
    Brown SM; Peltan ID; Webb B; Kumar N; Starr N; Grissom C; Buckel WR; Srivastava R; Harris ES; Leither LM; Johnson SA; Paine R; Greene T
    Ann Am Thorac Soc; 2020 Aug; 17(8):1008-1015. PubMed ID: 32425051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular Safety of Potential Drugs for the Treatment of Coronavirus Disease 2019.
    Aggarwal G; Henry BM; Aggarwal S; Bangalore S
    Am J Cardiol; 2020 Aug; 128():147-150. PubMed ID: 32425199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxychloroquine in Covid-19: Does the end justify the means?
    Yakoub-Agha I
    Curr Res Transl Med; 2020 Aug; 68(3):81-82. PubMed ID: 32340837
    [No Abstract]   [Full Text] [Related]  

  • 18. QT interval evaluation associated with the use of hydroxychloroquine with combined use of azithromycin among hospitalised children positive for coronavirus disease 2019.
    Tuncer T; Karaci M; Boga A; Durmaz H; Guven S
    Cardiol Young; 2020 Oct; 30(10):1482-1485. PubMed ID: 32686633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Test and treat COVID 65 plus - Hydroxychloroquine versus placebo in early ambulatory diagnosis and treatment of older patients with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Göpel S; Bethge W; Martus P; Kreth F; Iftner T; Joos S; Döbele S; Mordmüller B; Kremsner P; Ettrich T; Seufferlein T; Bitzer M; Malek N
    Trials; 2020 Jul; 21(1):635. PubMed ID: 32650818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 in a young liver transplant recipient: caution for drug-drug interactions.
    Dajti E; Cristini F; Tamanini G; Cescon M; Bazzoli F; Tamè M
    J Gastrointestin Liver Dis; 2020 Sep; 29(3):470. PubMed ID: 32830825
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.